According to the latest study from BCC Research, the "Global Fluorescence Microscopy Market" is expected to grow from $968.5 ...

We consider Cognizant’s financial position to be strong, given its low debt and comfortable cash levels. As of fiscal 2024, the company had $2 billion in cash, while reporting $908 million in debt.

"Life Sciences Drive Fluorescence Microscopy Market Growth Amid Rising Disease Prevalence and Technological Advances" BOSTON, April 30, 2025 /PRNewswire/ -- According to the latest study ...

While Zirinsky and members of her team have been held in high regard, “60 Minutes” staffers felt they were being put under a decidedly different microscope: one with a lens on how the show’s ...

In other cases, retroactive payment denials can stick patients with large, unexpected costs that compound the toll of illness. In the lead-up to annual meetings, publicly traded companies have ...

Germany has emerged as a popular launch location for DTx – or digital health applications (DiGA) in local parlance – thanks to Digital Healthcare Act (DVG), which has created an approval and ...

A common diabetes drug can reduce the pain of people with knee osteoarthritis and overweight or obesity, possibly delaying the need for knee replacements, Monash University-led research has found.

You can now sign up for a Red Pitaya Webinar to explore scalable, cost-effective test solutions for engineers, researchers, and system integrators.